Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1258-1267

  Zhang, Shuzhong ^a   Morris, Marilyn E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AZIDOPINE; BIOCHANIN A; DAUNORUBICIN; DOXORUBICIN; FLAVONOID; GLYCOPROTEIN P; MORIN; PHLORETIN; SILYMARIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; FRUIT; HUMAN; HUMAN CELL; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; VEGETABLE;

ADENOSINE TRIPHOSPHATASES; ANTIBIOTICS, ANTINEOPLASTIC; AZIDES; BIOLOGICAL TRANSPORT; DAUNORUBICIN; DIHYDROPYRIDINES; DOXORUBICIN; DRUG INTERACTIONS; FLAVONOIDS; GENISTEIN; HUMANS; P-GLYCOPROTEIN; PHLORETIN; PHOTOAFFINITY LABELS; SILYMARIN; TIME FACTORS; TRANSFECTION; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0037371275     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044412     Document Type: Article

References (41)

1. al-Shawi MK and Senior AE (1993) Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J Biol Chem 268:4197-4206.
2. Arora A, Byrem TM, Nair MG, and Strasburg GM (2000) Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys 373: 102-109.
3. Benderra Z, Trussardi A, Morjani H, Villa AM, Doglia SM, and Manfait M (2000) Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein. Eur J Cancer 36:428-434.
4. Castro AF and Altenberg GA (1997) Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 53:89-93.
5. Christensen JG and LeBlanc GA (1996) Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol. CancerRes 56:574-581.
6. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash DC) 258: 1650-1654.
7. Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, and Di Pietro A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95:9831-9836.
8. Drori S, Eytan GD, and Assaraf YG (1995) Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem 228:1020-1029.
9. Duggan J, Peterson WS, Schutz M, Khuder S, and Charkraborty J (2001) Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS 15:159-167.
10. Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, and Fattinger K (2000) St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598-604.
11. Fairchild CR, Moscow JA, O'Brien EE, and Cowan KH (1990) Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Mol Pharmacol 37:801-809.
12. Frezard F and Garnier-Suillerot A (1991) Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells. Eur J Biochem 196:483-491.
13. Fromm MF, Kim RB, Stein CM, Wilkinson GR, and Roden DM (1999) Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99:552-557.
14. Germann UA (1996) P-glycoprotein: a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A:927-944.
15. Gottesman MM and Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427.
16. Harborne J (1986) Nature, distribution and function of plant flavonoids, in Plant Flavonoids in Biology and Medicine: Biochemical Pharmacological and Structure-Activity Relationships, pp 17-28, Alan R. Liss, Inc., New York.
17. Juliano RL and Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162.
18. Kartner N, Riordan JR, and Ling V (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Wash DC) 221:1285-1288.
19. Kiso S, Cai SH, Kitaichi K, Furui N, Takagi K, Nabeshima T, and Hasegawa T (2000) Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. Anticancer Res 20:2827-2834.
20. Kuhnau J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24:117-191.
21. Leonessa F, Green D, Licht T, Wright A, Wingate-Legette K, Lippman J, Gottesman MM, and Clarke R (1996) MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer 73:154-161.
22. List AF (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10:937-942.
23. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, and Schinkel AH (1997) Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100: 2430-2436.
24. Middleton E Jr, Kandaswami C, and Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 52:673-751.
25. Ni H, Simile C, and Hardy AM (2002) Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 40:353-358.
26. Nooter K and Sonneveld P (1994) Clinical relevance of P-glycoprotein expression in haematological malignancies. Leukoc Res 18:233-243.
27. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, and Falloon J (2000) Indinavir concentrations and St. John's wort. Lancet 355:547-548.
28. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, and Falloon J (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234-238.
29. Schinkel AH (1998) Pharmacological insights from P-glycoprotein knockout mice. Int J Clin Pharmacol Ther 36:9-13.
30. Shapiro AB, Fox K, Lam P, and Ling V (1999) Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur J Biochem 259:841-850.
31. Shapiro AB and Ling V (1994) ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 269:3745-3754.
32. Shapiro AB and Ling V (1997a) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53:587-596.
33. Shapiro AB and Ling V (1997b) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130-137.
34. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112.
35. Song S, Suzuki H, Kawai R, and Sugiyama Y (1999) Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug Metab Dispos 27:689-694.
36. Tamai I and Safa AR (1991) Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 266:16796-16800.
37. Tseng E, Liang W, and Morris ME (2001) Effect of flavonoids on P-glycoprotein-mediated transport in a human breast cancer cell line, Poster presentation at the Annual Meeting of the American Association of Pharmaceutical Scientists, October 21-25, 2001, Denver CO. Pharm Res 3.
38. Tsuruo T, Iida H, Tsukagoshi S, and Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972.
39. Urbatsch IL, Sankaran B, Weber J, and Senior AE (1995) P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 270:19383-19390.
40. Volm M (1998) Multidrug resistance and its reversal. Anticancer Res 18:2905-2917.
41. Yu DK (1999) The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol 39:1203-1211.